Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3215]

Adjusting treatment based on early response to chemo boosts survival in Philadelphia chromosome-like acute lymphoblastic leukaemia

Adjusting treatment based on early response to chemo boosts survival in Philadelphia chromosome-like acute...

Study identifies potential drug combination for mantle cell lymphoma and chronic lymphocytic leukaemia

Study identifies potential drug combination for mantle cell lymphoma and chronic lymphocytic leukaemia

Inhibitor of RNA polymerase I shows promise as potential treatment for acute myeloid leukaemia and multiple myeloma

Inhibitor of RNA polymerase I shows promise as potential treatment for acute myeloid leukaemia and multiple myeloma

Study finds a new approach to tackle drug resistance in haematologic malignancies

Study finds a new approach to tackle drug resistance in haematologic malignancies

Drugs approved to treat other cancer types may improve treatment outcome for a type of childhood leukemia

Drugs approved to treat other cancer types may improve treatment outcome for a type of childhood leukemia

New type of targeted therapy shows promise in preclinical models of B-cell malignancy

New type of targeted therapy shows promise in preclinical models of B-cell malignancy

The war on leukaemia: How the battle for cell production could be decisive

The war on leukaemia: How the battle for cell production could be decisive

PET-CT predicts lymphoma survival better than conventional imaging

PET-CT predicts lymphoma survival better than conventional imaging

Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse?

Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse?

Study shows benefits of continuous treatment of lenalidomide plus dexamethasone in multiple myeloma

Study shows benefits of continuous treatment of lenalidomide plus dexamethasone in multiple myeloma

More from ecancer